An Open-label, Uncontrolled Study of ONO-7913 and ONO-4538 in Combination With Modified FOLFIRINOX Therapy, the Standard of Care, as First-line Treatment in Patients With Metastatic Pancreatic Cancer
An Open-label, Uncontrolled Study of ONO-7913 and ONO-4538 in Combination With Modified FOLFIRINOX Therapy, the Standard of Care, as First-line Treatment in Patients With Metastatic Pancreatic Cancer
Active, not recruiting · NCT06532344 · Registry updated 2026-10-07Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| An Open-label, Uncontrolled Study of ONO-7913 and ONO-4538 in Combination With Modified FOLFIRINOX Therapy, the Standard of Care, as First-line Treatment in Patients With Metastatic Pancreatic Cancer | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, endocrine system disorder, malignant endocrine neoplasm, neoplasm, pancreas disorder, pancreatic neoplasm | Active, not recruiting | Phase 1 | 2026-10-07 | NCT06532344 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Ono Pharmaceutical Co., Ltd. | 47 |
9 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Juntendo University Hospital | Bunkyō-Ku | Japan | 1 |
| Kanagawa Cancer Center | Yokohama | Japan | 10 |
| Keio University Hospital | Shinjuku-Ku | Japan | 9 |
| Kyorin University Hospital | Mitaka-shi | Japan | 1 |
| National Cancer Center Hospital | Chūōku | Japan | 9 |
| National Cancer Center Hospital East | Kashiwa-shi | Japan | 11 |
| Seirei Hamamatsu General Hospital | Hamamatsu | Japan | 4 |
| The Cancer Institute Hospital ofJFCR | Koto-ku | Japan | 1 |
| The University of Tokyo Hospital | Bunkyō-Ku | Japan | 3 |